Rocatinlimab – Talk Bio

Actionable Insights Powered by AI

AAD25: Amgen makes its OX40 case in atopic dermatitis

1 month ago talkbio0Tagged amgen, Effectiveness, Rocatinlimab

Rocatinlimab, Effectiveness, Amgen

Amgen’s Mixed Results: A Tale of Two Readouts in Eczema and Myasthenia Gravis Trials

7 months ago talkbio0Tagged amgen, Biotechnology, Clinical Trials, Drug Industry, Eczema, Myasthenia Gravis, Rocatinlimab

Amgen, Clinical Trials, Eczema, Myasthenia Gravis, Rocatinlimab, Uplizna, Biotechnology, Pharmaceutical Industry